|Articles|June 1, 2019
- Applied Clinical Trials-06-01-2019
- Volume 28
- Issue 6
Applied Clinical Trials, June 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Master Protocol Guidance in Cancer R&D: Impact on Industryover 6 years ago
The Benefits of RWD & RWE in Oncology Trialsover 6 years ago
Glimpsing the Future of Clinical Trial Designover 6 years ago
FDA Facilitates Expanded Access for Cancer Drugsover 6 years ago
News Notesover 6 years ago
Navigating Drug Development Through More Turbulent Watersover 6 years ago
Building a Physician Referral Network: A Case Studyover 6 years ago
Reveling in 2018's Revealing Drug and Biologic ApprovalsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Streamlining Clinical Data to Reduce Site and Participant Burden
3
Utilizing Tech Tools to Accelerate Drug Development
4
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
